MedPath

Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles

Phase 2
Completed
Conditions
Photodamaged Skin
Wrinkles
Interventions
Registration Number
NCT01283464
Lead Sponsor
Johns Hopkins University
Brief Summary

The purpose of this study is to assess the comparative efficacy of retinol 1.0% and tretinoin 0.02% in minimizing wrinkles, discoloration, roughness, and other signs of moderate to severe photodamage. Our hypothesis is that both products will be of comparable benefit.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Age 35 or over
  • Moderate to severe photodamage
Exclusion Criteria
  • History of facial cosmetic surgery, facial resurfacing procedures, deep peels, or facial fillers
  • History of keloids or hypertrophic scars
  • Use of oral steroids or oral retinoids (such as Accutane) in past 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RetinolRetinolRetinol 1.0% cream
TretinoinTretinoinTretinoin 0.02% cream
Primary Outcome Measures
NameTimeMethod
Global Photodamage SeverityWeek 24

A photonumeric scale for the assessment of cutaneous photodamage (CE Griffiths, et al). Five photographic standards (en face and 45 degrees oblique) illustrating increasing severity of photodamage (min=0, max=8) where 0=no damamge; 2=mild damage; 4=moderate damage; 6=moderate/severe damage; and grade 8=severe damage.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Hopkins Dept. of Dermatology

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath